First level agreements were signed with Johnson and Johnson, Moderna and Sputnik-Gamaleya
The Government of Ecuador announced early Wednesday that it has signed first-level agreements with the Johnson and Johnson, Moderna and Sputnik-Gamaleya laboratories, to obtain doses of vaccines against COVID-19.
In addition, previous dialogues and negotiations continue with Sinopharm, Cansino Biologics and Novavax for the acquisition of additional does of their vaccines.
Weeks ago, the Vice President of the Republic, María Alejandra Muñoz, announced that the current regime has negotiated 20,097,155 COVID-19 vaccine doses to be administered in the country.
Of these, 5,390,100 doses will arrive in the country during the first half of 2021; prior to today’s announcement, 14,707,055 doses were scheduled to arrive in the national territory in the second half of this year. The government has not yet indicated how these new agreements may impact the rollout of the COVID-19 vaccine.